Quick Answer
REVELATION BIOSCIENCES, INC. reported Cash and Equivalents of $10.70 million for fiscal year 2025.
REVELATION BIOSCIENCES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $10.70M | +64.6% |
| 2024 | $6.50M | -45.8% |
| 2023 | $11.99M | +128.3% |
| 2022 | $5.25M | +312.1% |
| 2021 | $1.27M | +10763.6% |
| 2020 | $11.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.71M | +94.3% | +145.6% |
| June 30, 2025 | $5.17M | -57.1% | +39.7% |
| March 31, 2025 | $3.70M | -74.5% | -43.0% |
| December 31, 2024 | $6.50M | -45.8% | -0.6% |
| September 30, 2024 | $6.54M | -53.3% | -45.8% |
| June 30, 2024 | $12.07M | -23.2% | -17.0% |
| March 31, 2024 | $14.55M | -17.8% | +21.3% |
| December 31, 2023 | $11.99M | +128.3% | -14.3% |
- REVELATION BIOSCIENCES, INC. showed an increase of +64.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, REVELATION BIOSCIENCES, INC.’s cash and equivalents has grown by 91090.8% (from $11.7 thousand to $10.70 million).
- The most recent figure is from REVELATION BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: